Table 1.
Cytokines involved in cachexia, function, and specific targeted therapies
Cytokine | Function | Drug |
TGF-β | Decreases protein synthesis; increases muscle catabolism | Trabedersen (binds TGF-β mRNA) |
TNF-α | Generates radical oxygen species; increases ubiquitin-proteasome activity | Infliximab (anti-TNF-α mAb); etanercept (recombinant TNF-αR); thalidomide/lenalidomide (inhibits TNF-α); pentoxifylline (inhibits TNF-α) |
IL-6 | Mediates systemic inflammation; increases muscle catabolism; regulates synthesis of acute phase reactants | Clazakizumab (anti-IL-6 mAb ); tocilizumab (anti-IL-6 receptor mAb) |
TGF-β: Transforming growth factor-beta; IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-alpha.